IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,060 | -0.5% | 2,250,000 | -10.0% | 3.36% | +0.7% |
| Q2 2023 | $102,575 | +49.1% | 2,500,000 | +29.9% | 3.34% | +57.8% |
| Q1 2023 | $68,800 | -5.4% | 1,925,000 | 0.0% | 2.12% | -15.2% |
| Q4 2022 | $72,707 | -99.9% | 1,925,000 | 0.0% | 2.49% | -4.3% |
| Q3 2022 | $85,143,000 | -14.8% | 1,925,000 | -28.7% | 2.61% | -39.9% |
| Q2 2022 | $99,954,000 | -10.0% | 2,700,000 | -10.0% | 4.34% | +7.9% |
| Q1 2022 | $111,120,000 | +162.7% | 3,000,000 | +115.8% | 4.02% | +176.5% |
| Q4 2021 | $42,298,000 | -49.6% | 1,390,000 | -44.4% | 1.45% | -43.7% |
| Q3 2021 | $83,850,000 | +5.1% | 2,500,000 | +25.0% | 2.58% | -3.9% |
| Q2 2021 | $79,780,000 | +77.4% | 2,000,000 | +100.0% | 2.69% | +74.2% |
| Q1 2021 | $44,960,000 | – | 1,000,000 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |